COVID-19 and hyperglycemia/diabetes.
World J Diabetes
; 12(5): 642-650, 2021 May 15.
Article
in English
| MEDLINE | ID: covidwho-1231557
ABSTRACT
In early studies regarding coronavirus disease 2019 (COVID-19), type 2 diabetes mellitus was considered to contribute substantially to the disease's inflammatory response. Subsequently, even hyperglycemia, regardless of insulin resistance or diabetes mellitus, was found to be additionally harmful. Recent studies have shown inflammation of the pancreatic ß cells in COVID-19, even leading to new onset diabetes mellitus. We hereby summarize core literature on glycemia and COVID-19, and present implicated pathways and mechanisms.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
World J Diabetes
Year:
2021
Document Type:
Article
Affiliation country:
Wjd.v12.i5.642
Similar
MEDLINE
...
LILACS
LIS